There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Accelerate Diagnostics Inc. (AXDX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.01, or 1.96%, to $0.52. The Accelerate Diagnostics Inc. has recorded 8,146 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Accelerate Diagnostics submits 510(K) application to FDA for Gram-negative menu expansion and breakpoint updates for the Accelerate PhenoTest® BC kit.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
As a NASDAQ listed company, AXDX falls under the Healthcare sector while operating within the Medical Devices industry segment. At the end of the last regular session, the stock closed at $0.51 and fluctuated between $0.5139 as its day high and $0.4650 as its day low. The current market capitalization of Accelerate Diagnostics Inc. is $53.98M. A total of 0.51 million shares were traded on the day, compared to an average of 295.24K shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, AXDX has seen 3 BUY and 2 SELL insider trades, representing the acquisition of 36,655 and the disposition of 13,138 shares. Over the last 12 months, there were 10 BUYs and 6 SELLs from insiders. Insiders purchased 472,451 shares during that period but sold 170,031.
In the most recent transaction, Phillips Jack sold 8,601 shares of AXDX for 0.60 per share on Feb 13. After the transaction, the Chief Executive Officer now owns 269,458 company shares. In a previous transaction on Feb 13, REICHLING STEVEN sold 4,823 shares at 0.60 per share. AXDX shares that Chief Financial Officer owns now total 76,818.
Among the insiders who sold shares, Phillips Jack disposed of 8,408 shares on Jan 13 at a per-share price of $0.69. This resulted in the Chief Executive Officer holding 250,843 shares of AXDX after the transaction. In another insider transaction, REICHLING STEVEN sold 4,730 shares at $0.69 per share on Jan 13. Company shares held by the Chief Financial Officer now total 72,202.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for AXDX in the last 3 months, the mean price target is $2.00 with high estimates of $2.00 and low estimates of $2.00. In terms of 52-week highs and lows, AXDX has a high of $3.74 and a low of $0.46.
As of this writing, AXDX has an earnings estimate of -$0.15 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.13 per share and a lower estimate of -$0.17. The company reported an EPS of -$0.23 in the last quarter, which was 17.90% higher than expectations of -$0.28.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 2 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AXDX is Buy with a score of 4.00. A total of 1 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.